Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05060627
Title An Open Label, Multicenter, Phase I/II Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors PETHEMA Foundation
Age Groups: adult | senior
Covered Countries ESP

No variant requirements are available.